|
16 Companies |
|
21 Products |
|
21 Products |
|
17 Mechanisms of Action |
|
0 Trials |
|
174 News |
|
| «1234» |
- Enrollment open: Choline Dehydrogenase and Sperm Function: Effects of Betaine (clinicaltrials.gov) - Apr 21, 2014
P1, N=15, Recruiting, Sponsor: University of North Carolina, Chapel Hill
Not yet recruiting --> Recruiting
- Enrollment closed: Sperm Banking Among Adolescents Newly Diagnosed With Cancer: Development of a Profiling and Referral Tool (clinicaltrials.gov) - Apr 21, 2014
P=N/A, N=618, Active, not recruiting, Sponsor: St. Jude Children's Research Hospital
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- ||||| Androxal (enclomifene) / AbbVie
Enrollment closed: A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62% (clinicaltrials.gov) - Apr 14, 2014
P3, N=120, Active, not recruiting, Sponsor: Repros Therapeutics Inc.
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- Enrollment open: IMSI in Couples With Previous Implantation Failures (clinicaltrials.gov) - Apr 7, 2014
P=N/A, N=386, Recruiting, Sponsor: Sapientiae Institute
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- Trial completion, Preclinical: Effectiveness of Intracytoplasmic Sperm Injection and Laser Assisted Hatching on in Vitro Fertilization Outcomes of Patients With Different Causes of Infertility (clinicaltrials.gov) - Mar 29, 2014
P=N/A, N=375, Completed, Sponsor: Far Eastern Memorial Hospital
Not yet recruiting --> Recruiting Recruiting --> Completed
- atorvastatin / Generic mfg.
New P1 trial: Effects of Atorvastatin on Human Semen and Gonadal Hormones (clinicaltrials.gov) - Mar 19, 2014
P1, N=17, Completed, Sponsor: University Hospital, Clermont-Ferrand
- Trial completion, Preclinical: TBA on IVF: Impact of Sperm DNA Integrity on In Vitro Cycles (clinicaltrials.gov) - Mar 13, 2014
P=N/A, N=420, Completed, Sponsor: North Shore Long Island Jewish Health System
Recruiting --> Completed Active, not recruiting --> Completed
- Ovidrel (choriogonadotropin alfa) / EMD Serono
Trial termination: The Effect of a Dual Trigger on Intracytoplasmic Sperm Injection (ICSI) Reproductive Outcomes (clinicaltrials.gov) - Feb 21, 2014
P4, N=400, Terminated, Sponsor: Antalya IVF
Active, not recruiting --> Completed Recruiting --> Terminated; treatment strategy changed
- New P2 trial: ROS: Use of Antioxidant in Endometriotic Women to Improve Intracytoplasmic Sperm Injection (ICSI) (clinicaltrials.gov) - Feb 6, 2014
P2, N=50, Completed, Sponsor: Cairo University
- desogestrel/ethinylestradiol / Generic mfg.
Trial completion: FOLLPRIM: Antral Follicle Priming Prior to ICSI (Intracytoplasmic Sperm Injection) in Previously Diagnosed Low Responders (clinicaltrials.gov) - Feb 6, 2014
P2, N=66, Completed, Sponsor: Instituto de Investigacion Sanitaria La Fe
Recruiting --> Terminated; treatment strategy changed Not yet recruiting --> Completed
- New P4 trial: Fertilizations With Immotile Sperm: Pentoxyphylline Activation Alone, or With Chemical Oocyte Activation (clinicaltrials.gov) - Jan 29, 2014
P4, N=50, Not yet recruiting, Sponsor: Rambam Health Care Campus
- |||||| Androxal (enclomifene) / AbbVie
Enrollment open: A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62% (clinicaltrials.gov) - Jan 15, 2014
P3, N=120, Recruiting, Sponsor: Repros Therapeutics Inc.
Not yet recruiting --> Completed Not yet recruiting --> Recruiting
- | New P2 trial: Reduction of Sperm DNA Fragmentation by Oral Ginger (clinicaltrials.gov) - Jan 7, 2014
P2, N=71, Completed, Sponsor: Royan Institute
- Trial completion: Reduction of Sperm DNA Fragmentation by Oral Ginger (clinicaltrials.gov) - Jan 7, 2014
P2, N=71, Completed, Sponsor: Royan Institute
Not yet recruiting --> Recruiting Not yet recruiting --> Completed
- Fostimon (purified hFsh) / IBSA Institute Biochemical SA, Follistim AQ Cartridge (follitropin beta) / Organon
Trial initiation date: Time-lapse Monitoring of Early Embryo Development After Ovarian Stimulation During Infertility Treatment (clinicaltrials.gov) - Jan 6, 2014
P=N/A, N=150, Recruiting, Sponsor: St. Olavs Hospital
Not yet recruiting --> Completed Initiation date: Jun 2013 --> Oct 2013
- Fostimon (purified hFsh) / IBSA Institute Biochemical SA, Follistim AQ Cartridge (follitropin beta) / Organon
Enrollment open: Time-lapse Monitoring of Early Embryo Development After Ovarian Stimulation During Infertility Treatment (clinicaltrials.gov) - Jan 6, 2014
P=N/A, N=150, Recruiting, Sponsor: St. Olavs Hospital
Initiation date: Jun 2013 --> Oct 2013 Not yet recruiting --> Recruiting
- Enrollment open: VATES: Relationship Between Sperm Head Vacuoles and Sperm DNA Alterations in Infertile Men (clinicaltrials.gov) - Jan 5, 2014
P=N/A, N=200, Recruiting, Sponsor: University Hospital, Rouen
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- |||||||||| Androxal (enclomifene) / AbbVie
New P3 trial: A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62% (clinicaltrials.gov) - Nov 21, 2013
P3, N=120, Active, not recruiting, Sponsor: Repros Therapeutics Inc.
- |||||||||| Androxal (enclomifene) / AbbVie
New P3 trial: A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62% (clinicaltrials.gov) - Nov 21, 2013
P3, N=120, Recruiting, Sponsor: Repros Therapeutics Inc.
- ||| Enrollment open, Preclinical: The ERA Test as a Diagnostic Guide for Personalized Embryo Transfer (clinicaltrials.gov) - Nov 10, 2013
P=N/A, N=2442, Recruiting, Sponsor: Iviomics
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- Ovidrel (choriogonadotropin alfa) / EMD Serono
New P4 trial: The Effect of a Dual Trigger on Intracytoplasmic Sperm Injection (ICSI) Reproductive Outcomes (clinicaltrials.gov) - Nov 6, 2013
P4, N=400, Terminated, Sponsor: Antalya IVF
- | cabergoline / Generic mfg.
Enrollment open: Cabergoline and Coasting to Prevent OHSS (clinicaltrials.gov) - Nov 6, 2013
P3, N=200, Recruiting, Sponsor: Cairo University
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- || cabergoline / Generic mfg.
New P3 trial: Cabergoline and Coasting to Prevent OHSS (clinicaltrials.gov) - Oct 30, 2013
P3, N=200, Recruiting, Sponsor: Cairo University
- Enrollment closed, Preclinical: inSIGHT: SIGnificance of Routine Hysteroscopy Prior to a First 'in Vitro Fertilization'(IVF) Treatment Cycle (clinicaltrials.gov) - Oct 28, 2013
P4, N=738, Active, not recruiting, Sponsor: UMC Utrecht
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- ||||||| Androxal (enclomifene) / AbbVie
Trial completion, P3 data: Phase III Study to Evaluate Morning Testosterone Normalization in Overweight Men With Secondary Hypogonadism (clinicaltrials.gov) - Oct 21, 2013
P3, N=181, Completed, Sponsor: Repros Therapeutics Inc.
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- Trial completion, Preclinical: Study to Examine Effect of Recombinant Luteinizing Hormone (r-Lh) and Recombinant Human Chorionic Gonadotropin (r-hCG) for Ovarian Stimulation in Assisted Reproduction Techniques (ART) (clinicaltrials.gov) - Sep 24, 2013
P4, N=100, Completed, Sponsor: Regionshospitalet Viborg, Skive
Active, not recruiting --> Completed Recruiting --> Completed
- ramipril / Generic mfg.
Enrollment open: Ramipril for the Treatment of Oligospermia (clinicaltrials.gov) - Sep 4, 2013
P=N/A, N=60, Recruiting, Sponsor: Weill Medical College of Cornell University
Recruiting --> Completed Not yet recruiting --> Recruiting
- | Enrollment change: FOLFIV: Impact of Folates in the Care of the Male Infertility (clinicaltrials.gov) - Aug 1, 2013
P3, N=368, Recruiting, Sponsor: Assistance Publique - H
Not yet recruiting --> Recruiting N=780 --> 368
- Enrollment open: Application of MACS and Time-lapse Technology in Good-prognosis Patients (clinicaltrials.gov) - Jul 31, 2013
P=N/A, N=200, Recruiting, Sponsor: IVI Sevilla
N=780 --> 368 Not yet recruiting --> Recruiting
- Trial completion: FERTIFORT: Sperm Morphology by High Magnification in Fertility Men (clinicaltrials.gov) - Jul 3, 2013
P=N/A, N=54, Completed, Sponsor: University Hospital, Toulouse
Not yet recruiting --> Recruiting Not yet recruiting --> Completed
- | New P4 trial: Preimplantation Genetic Diagnosis (PGD) With Gonadotropin-releasing Hormone (GnRH) Agonist Versus Antagonist (clinicaltrials.gov) - Jun 26, 2013
P4, N=120, Completed, Sponsor: Universitair Ziekenhuis Brussel
- Trial completion: Timing of Intrauterine Insemination (IUI) 24 or 48 Hours After Spontaneous Luteinizing Hormone (LH) Peak (clinicaltrials.gov) - Jun 23, 2013
P4, N=435, Completed, Sponsor: Universitair Ziekenhuis Brussel
Not yet recruiting --> Completed Recruiting --> Completed
- || New P2/3 trial, Preclinical, Biopsy: A Study to Assess if Scratching the Lining of the Womb Prior to IVF Treatment Increases the Chances of Pregnancy (clinicaltrials.gov) - Jun 18, 2013
P2/3, N=160, Recruiting, Sponsor: Nottingham University Hospitals NHS Trust
- Enrollment change: Effect of Omega 3 Fats on Sperm Quality and Sexual Function (clinicaltrials.gov) - Jun 2, 2013
P2, N=6, Terminated, Sponsor: Reproductive Partners Medical Group
Recruiting --> Completed N=46 --> 6
- ||||||| Androxal (enclomifene) / AbbVie
Trial completion, P3 data: Phase III Study to Evaluated Morning Testosterone Normalization in Men With Secondary Hypogonadism (clinicaltrials.gov) - May 15, 2013
P3, N=151, Completed, Sponsor: Repros Therapeutics Inc.
N=46 --> 6 Active, not recruiting --> Completed
- Clinical: Endometrial Injury and Single Embryo Transfer (clinicaltrials.gov) - May 9, 2013
P=N/A, N=118, Completed, Sponsor: Karadeniz Technical University
- Surgery, Bariatric surgery: BARIASPERM: Bariatric Surgery and Sperm Quality (clinicaltrials.gov) - Apr 25, 2013
P=N/A, N=45, Recruiting, Sponsor: Assistance Publique - Hôpitaux de Paris
- | Suprefact (buserelin acetate) / Sanofi
New P4 trial, Preclinical: Age Versus Ovarian Reserve Markers Based Therapy in IVF (IVF)/Intracytoplasmic Sperm Injection (ICSI) Cycles (clinicaltrials.gov) - Mar 20, 2013
P4, N=360, Recruiting, Sponsor: Andros Day Surgery Clinic
- Preclinical, Enrollment change: Human Sperm Binding to Transgenic Mouse Eggs (clinicaltrials.gov) - Mar 5, 2013
P=N/A, N=13, Completed, Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Active, not recruiting --> Completed N=40 --> 13
- Enrollment open: Motile Sperm Organelle Morphology Examination (MSOME) Influence on Intracytoplasmic Sperm Injection (ICSI) Outcomes in Infertile Couples (clinicaltrials.gov) - Jan 6, 2013
P=N/A, N=72, Recruiting, Sponsor: Sapientiae Institute
N=40 --> 13 Not yet recruiting --> Recruiting
- Enrollment open: Influence of Sperm With Large Nuclear Vacuole on ICSI Outcomes (clinicaltrials.gov) - Jan 6, 2013
P=N/A, N=200, Recruiting, Sponsor: Sapientiae Institute
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- Trial completion, Metastases: IMSIAMA: Intracytoplasmic Morphologically Selected Sperm Injection and Advanced Maternal Age (clinicaltrials.gov) - Jan 6, 2013
P=N/A, N=66, Completed, Sponsor: Sapientiae Institute
Not yet recruiting --> Recruiting Recruiting --> Completed
- Cetrotide (cetrorelix) / EMD Serono
Trial termination: Cetrotide Treatment Optimization (clinicaltrials.gov) - Dec 20, 2012
P4, N=617, Terminated, Sponsor: Bart CJM Fauser
Recruiting --> Completed Recruiting --> Terminated; Due to limited rate of patient inclusion
- Cetrotide (cetrorelix) / EMD Serono
Enrollment change: Cetrotide Treatment Optimization (clinicaltrials.gov) - Dec 20, 2012
P4, N=617, Terminated, Sponsor: Bart CJM Fauser
Recruiting --> Terminated; Due to limited rate of patient inclusion N=2430 --> 617
- Nestorone MDTS (elcometrine transdermal spray) / Population Council
Trial completion: CCN007: Study of the Safety, and Sperm and Gonadotropin Suppression of a Contraceptive Gel in Normal Men (clinicaltrials.gov) - Dec 13, 2012
P1, N=99, Completed, Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
N=2430 --> 617 Active, not recruiting --> Completed
- Enrollment closed: Effects of Plant Extracts on Semen Quality (clinicaltrials.gov) - Dec 3, 2012
P=N/A, N=100, Active, not recruiting, Sponsor: Horsens Hospital
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- |||||||||| Androxal (enclomifene) / AbbVie
New P3 trial, P3 data: Phase III Study to Evaluate Morning Testosterone Normalization in Overweight Men With Secondary Hypogonadism (clinicaltrials.gov) - Nov 29, 2012
P3, N=181, Completed, Sponsor: Repros Therapeutics Inc.
- Trial completion: Does Flushing the Uterine Cavity With Follicular Fluid After Ovum Pick-up Improve Implantation Rates in ICSI Cycles? (clinicaltrials.gov) - Oct 5, 2012
P1, N=100, Completed, Sponsor: Nawara Mohamed Hashish
Recruiting --> Active, not recruiting Recruiting --> Completed
- Enrollment change: Sperm Banking Among Adolescents Newly Diagnosed With Cancer: Development of a Profiling and Referral Tool (clinicaltrials.gov) - Aug 21, 2012
P=N/A, N=618, Active, not recruiting, Sponsor: St. Jude Children's Research Hospital
Recruiting --> Completed N=206 --> 618
- Ovidrel (choriogonadotropin alfa) / EMD Serono
Preclinical, Trial initiation date: EXpression PRofile Endometrium Samples Study (clinicaltrials.gov) - Jul 2, 2012
P4, N=27, Terminated, Sponsor: Merck KGaA
N=206 --> 618 Initiation date: Dec 2007 --> Aug 2008